These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2141150)

  • 21. Training dogs to differentiate
    Davies JC; Alton E; Simbo A; Murphy R; Seth I; Williams K; Somerville M; Jolly L; Morant S; Guest C
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31413160
    [No Abstract]   [Full Text] [Related]  

  • 22. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa.
    Farinde A
    Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292
    [No Abstract]   [Full Text] [Related]  

  • 23. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation.
    Edenborough FP; Stone HR; Kelly SJ; Zadik P; Doherty CJ; Govan JR
    J Cyst Fibros; 2004 Mar; 3(1):37-44. PubMed ID: 15463885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biofilms, antimicrobial resistance, and airway infection.
    Prince AS
    N Engl J Med; 2002 Oct; 347(14):1110-1. PubMed ID: 12362015
    [No Abstract]   [Full Text] [Related]  

  • 26. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
    Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
    Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serology of anti-Pseudomonas aeruginosa and mucoviscidosis: diagnostic aid in the differentiation between colonization and infection].
    Recule C; Croizé J; Coppéré C; Hirtz P; Goût JP; Le Noc P
    Pathol Biol (Paris); 1993 Mar; 41(3):249-54. PubMed ID: 8332395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas colonization in cystic fibrosis. A study of 160 patients.
    Kulczycki LL; Murphy TM; Bellanti JA
    JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of efflux pump inhibitors phenyl-arginine-beta-naphthylamide and 1-(1-naphthylmethyl)-piperazine on the antimicrobial susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Coban AY; Tanriverdi Cayci Y; Erturan Z; Durupinar B
    J Chemother; 2009 Nov; 21(5):592-4. PubMed ID: 19933053
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.
    Dolce D; Cariani L; Campana S; Ravenni N; Mergni G; Biffi A; Colombo C; Gagliardini R; Cirilli N; Manso E; Padoan R; Soncini E; Forte FR; D'Aprile A; Ratclif L; Amboni M; Casciaro R; Minicucci L; Borio T; Cosimi A; Vieni G; Zinnarello C; Fiscarelli E; Collura M; Pensabene T; Braggion C; Döring G; Taccetti G
    J Cyst Fibros; 2014 Jan; 13(1):116-7. PubMed ID: 24022018
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 32. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
    Dalzell AM; van Saene HK; Heaf DP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):40-1. PubMed ID: 2130715
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C; Skov M
    Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
    Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
    J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.
    Lawrence D
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978345
    [No Abstract]   [Full Text] [Related]  

  • 38. Cystic fibrosis and oral health.
    Tynan JJ; Komiyama K
    J Can Dent Assoc; 1984 Nov; 50(11):833-5. PubMed ID: 6391624
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa and cystic fibrosis--a nasty bug gets nastier.
    Aaron SD
    Respiration; 2006; 73(1):16-7. PubMed ID: 16498269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.